Insulin-sensitizing drugs (metformin, pioglitazone, d-chiro-inositol) have been introduced as a therapeutic option in PCOS, targeting reproductive and cardiometabolic abnormalities on the basis of its action on the reduction of glucose levels and the attenuation of IR [13]. This evidence concerns the gene INS and polycystic ovary syndrome.